Ibnsina Pharma (ISPH) Financial Statements
Annual financial statement highlights for Ibnsina Pharma, in Egyptian pounds (EGP) covering fiscal years 2015–2025. Figures are updated weekly from EGX filings via TradingView.
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Total assets | Total debt | DPS |
|---|---|---|---|---|---|---|---|
| 2025 | 76.6B | 771.11M | 0.765 | -805.66M | 36.21B | 26.67B | 0.13 |
| 2024 | 55.84B | 497.8M | 0.4938 | -1.18B | 28.64B | 20.19B | 0.16 |
| 2023 | 33.95B | 173.14M | 0.1718 | -228.23M | 18.55B | 13.13B | 0.00 |
| 2022 | 22.26B | 132.21M | 0.1312 | -436.52M | 12.86B | 9.85B | 0.00 |
| 2021 | 21.73B | 286.33M | 0.2566 | -487.96M | 11.28B | 7.98B | 0.1003 |
| 2020 | 18.68B | 184.11M | 0.1643 | 21.75M | 9.25B | 6.75B | 0.00 |
| 2019 | 16.6B | 303.17M | 0.2705 | -417.07M | 8.17B | 5.47B | 0.0512 |
| 2018 | 13.32B | 242.3M | 0.1933 | -745.58M | 6.36B | 4.54B | 0.0454 |
| 2017 | 9.59B | 170.14M | 0.1631 | 239.79M | 4.33B | 3.29B | 0.00 |
| 2016 | 7.21B | 101.75M | 0.0975 | 133.89M | 3.06B | 2.13B | — |
| 2015 | 5.33B | 57.36M | 0.055 | -11.28M | 2.21B | 1.61B | — |
All figures in EGP. Source: company disclosures to the Egyptian Exchange via TradingView; updated weekly.